Status:
COMPLETED
Peri-operative Cefazolin Prophylaxis at Time of Cesarean Delivery in the Obese Gravida
Lead Sponsor:
University of Pittsburgh
Conditions:
Obesity
Pregnancy
Eligibility:
FEMALE
18+ years
Phase:
PHASE1
Brief Summary
Obesity has become an increasingly prevalent public health problem in the United States, reaching epidemic proportions. According to 2009 CDC epidemiologic data on obesity in the United States, 35.7% ...
Eligibility Criteria
Inclusion
- Body mass index (BMI) greater than 30kg/m2
- Those women having scheduled primary or repeat cesarean delivery
Exclusion
- Type 1 and Type 2 Insulin Dependent Diabetes Mellitus
- Autoimmune disease, including systemic lupus erythematosus
- History of chronic renal disease
- Those using chronic corticosteroids
- Those with a history of a previous wound breakdown
- Those who have an allergy to cephalosporins whose reaction includes anaphylaxis, urticaria or other systemic consequences
- Those who are unable to receive their antibiotics in a timely fashion
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2014
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT01904500
Start Date
August 1 2013
End Date
April 1 2014
Last Update
August 18 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Magee-Women's Hospital/University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213